2018-01-02 - Male - 7 Years old
707221
| Adverse reaction report number | 707221 |
| Latest AER version number | 0 |
| Market authorization holder AER number | N/A |
| Initial received date | 2018-01-02 |
| Latest received date | 2018-01-02 |
| Age | 7 Years |
| Gender | Male |
| Weight | N/A |
| Type of report | Spontaneous |
| Reporter type | Other Health Professional |
| Source of report | Community |
| Report outcome | Unknown |
| Serious report? | No |
| Product description | Dosage form | Health product role | Route of administration | Dose | Frequency | Therapy duration | Indication(s) |
|---|---|---|---|---|---|---|---|
| ADDERALL XR 15MG | CAPSULE, EXTENDED RELEASE | Suspect | 10 Milligram | ||||
| ADDERALL XR 15MG | CAPSULE, EXTENDED RELEASE | Suspect | Oral | 15 Milligram |
| MedDRA version: v.21.1 | |
| Adverse reaction terms | Reaction duration |
|---|---|
| Attention deficit/hyperactivity disorder | |
| Drug ineffective | |
| Mydriasis | |
| Visual impairment | |